BeOne Medicines (BEIGF) Assets (QoQ) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Assets (QoQ) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.27% |
| Mar 31, 2026 | 4.46% |
| Dec 31, 2025 | 7.28% |
| Sep 30, 2025 | 21.18% |
| Jun 30, 2025 | 7.82% |
| Mar 31, 2025 | -1.34% |
| Dec 31, 2024 | 1.54% |
| Sep 30, 2024 | 2.08% |
| Jun 30, 2024 | 0.79% |
| Mar 31, 2024 | -2.37% |
| Dec 31, 2023 | 5.08% |
| Sep 30, 2023 | -3.56% |
| Jun 30, 2023 | -3.83% |
| Mar 31, 2023 | -6.62% |
| Dec 31, 2022 | -5.15% |
| Sep 30, 2022 | -8.84% |
| Jun 30, 2022 | -8.02% |
| Mar 31, 2022 | -6.02% |
| Dec 31, 2021 | 61.46% |
| Sep 30, 2021 | -4.30% |